Recent studies of EGFR-AT1R crosstalk have focused on cardiac hypertrophy (63), smooth vascular cell dysfunction (64), vascular remodeling (65), and ECM formation (66). The gene discussed is EGFR; the disease is cardiac hypertrophy.